Alnylam Pharmaceuticals
ALNY
#1123
Rank
S$27.03 B
Marketcap
S$201.82
Share price
3.61%
Change (1 day)
-64.92%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company